Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-TEST: Everolimus to Prevent Alloantibody Formation in Late Stage Renal Allograft Failure
NCT01636466Phase 3Terminated
- Start
- Jun 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in chronic kidney disease (CKD). Started Jun 2013; status: terminated.
02
Drugs
everolimus
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01636466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01636466.